FIRM NEWS

The trial team of Joseph Taraska and Scott Noecker of Jacobs & Goodman, P.A. obtained a verdict of $13,338,606.00 against a subsidiary of Johnson & Johnson on October 28, 2008. The verdict came about as a result of the utilization of a defectively manufactured Duragesic (Fentanyl) pain patch manufactured by Alza, a subsidiary of Johnson & Johnson. The patch was utilized by a 34-year old woman who was the mother of five. As a result of the use of the patch, she died in her sleep. The trial lasted three and one-half weeks with liability being divided: 80% against Alza Corporation and Janssen Pharmaceutica; and 20% against a physician’s assistant on a related medical malpractice case.

The firm is accepting referrals on Fentanyl pain patch related deaths, not only those manufactured by Janssen Pharmaceutica and Alza Corporation, subsidiaries of Johnson & Johnson, but Mylan (generic form) and Sandoz.